Baricitinib for treating juvenile idiopathic arthritis in people 2 years and over (terminated appraisal)

  • Technology appraisal
  • TA982
  • Published: 

History

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6143